Berkeley Lights, Inc. reiterated revenue guidance for full year 2022. For the period, the company reiterates full year 2022 revenue to grow approximately 30% compared to full year 2021.
Bruker Cellular Analysis, Inc.
Equities
BLI
US0843101017
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+45.83% | 56.65B | |
-7.01% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.44% | 19.03B | |
+0.88% | 12.28B | |
+23.98% | 12.26B | |
+27.11% | 12.04B |